New evidence shows opioid use and pain decline, quality of life goes up after cannabis treatment by Martin Lane June 10, 2021June 10, 2021 Data-driven drug development company Emyria has released new research indicating opioid use and pain decline in […]
Revealed: the studies that show medicinal cannabis could solve the opioid addiction crisis by Rachel Williamson May 13, 2021May 18, 2021
Emyria granted TGA approval for medical grade, smartphone-enabled, monitoring software by Martin Lane May 13, 2021May 13, 2021
Industry backs TGA over illicit cannabis but price remains a barrier for legal channels by Steve Jones May 6, 2021June 2, 2021
Company news: Little Green Pharma; Emyria; Health House; Australian Primary Hemp by Martin Lane April 21, 2021April 22, 2021
Emyria and Cann Group ink deal to fast track over-the-counter CBD registration by Martin Lane March 29, 2021March 29, 2021
US positivity flows across Pacific as local cannabis stocks surge by Steve Jones February 11, 2021February 11, 2021
